Latest Shareholder Approvals News

Page 7 of 388
Botala Energy has completed its A$1.35 million placement and is seeking up to a further A$1.5 million from existing shareholders at A$0.045 a share. The funds are earmarked for flow testing and production activities at the Pitse Pilot, exploration drilling and working capital.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Count Limited has entered FY2027 with sharper earnings momentum, record funds under management and a larger acquisition pipeline after shareholders approved all AGM resolutions. The company also outlined its biggest Equity Partnership investment yet, while maintaining a higher dividend and a $1.25 million Oracle synergy target.
Claire Turing
Claire Turing
9 Nov 2026
Starpharma is targeting a December start for first-in-human testing of its lead DEP HER2-Lu radiopharmaceutical, subject to ethics approval, as it shifts decisively toward targeted oncology. The company also outlined stronger funding, majority ownership of Petalion’s FAP program and a proposed Chair transition at its 2026 AGM.
Ada Torres
Ada Torres
6 Nov 2026
Riversgold has locked in $1.55 million from sophisticated and professional investors to fund its E25/594 acquisition from Black Cat Syndicate. The deal would expand the Kalgoorlie-Northern Zone Project nearly 15-fold, but more than 258 million new shares will be issued across two tranches.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Count has completed a fully underwritten $25.0 million institutional placement to help fund its planned acquisition of a 75% interest in Skybridge Financial Group. The acquisition still requires ACCC clearance or a notification waiver before completion, targeted for Q3 FY2027.
Claire Turing
Claire Turing
6 Nov 2026
Mayne Pharma will sell its international operations, including the Salisbury manufacturing site, to Evaris Pharma for $55.5 million in cash. The deal leaves the company focused entirely on its US Women’s Health, Dermatology and DistributeRx businesses, subject to ACCC approval.
Victor Sage
Victor Sage
6 Nov 2026
Hammer Metals has set 13 November for the Federal Court to consider approval of Austral Resources Australia’s proposed acquisition of the company. The hearing comes after shareholders are due to vote on the scheme and a linked demerger on 9 November.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Atlantic Lithium has secured court approval to put Huayou’s proposed acquisition to shareholders, setting a 14 December vote on the scheme. The transaction remains conditional, but the process has now moved from regulatory clearance to shareholder decision.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Peet shareholders have received the scheme booklet for Ingenia’s proposed acquisition, with an independent expert concluding the deal is fair and reasonable. The transaction now moves to a 7 December vote, with implementation targeted for 4 January 2027 if remaining approvals are secured.
Eva Park
Eva Park
5 Nov 2026
Noumi shareholders and optionholders have backed Arrovest’s proposed schemes, clearing the main voting hurdle in the takeover. The transaction still requires Supreme Court of New South Wales approval and satisfaction or waiver of other conditions.
Victor Sage
Victor Sage
5 Nov 2026
Neurizon says it has removed its remaining Obsidian convertible notes while targeting $6.3 million in new equity ahead of the pivotal NUZ-001 ALS readout. The funding plan reduces immediate conversion uncertainty, but the proposed Share Purchase Plan and possible future facility drawdown leave execution questions open.
Ada Torres
Ada Torres
5 Nov 2026
Northstone Resources has secured an oversubscribed $2.37 million placement as its shares return to trading, funding a run of technical and drilling milestones in Serbia. The raise puts a maiden JORC resource estimate for the Tlamino gold-silver project in sharper focus, while also adding substantial option exposure to the capital structure.
Maxwell Dee
Maxwell Dee
5 Nov 2026

Browse the archive

Full archive